{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:15:03Z","timestamp":1776856503936,"version":"3.51.2"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54 DK126108"],"award-info":[{"award-number":["U54 DK126108"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA273016"],"award-info":[{"award-number":["R01 CA273016"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute B-cell lymphoblastic leukemia (B-ALL) results from oligo-clonal evolution of B-cell progenitors endowed with initiating and propagating leukemia properties. The activation of both the Rac guanine nucleotide exchange factor (Rac GEF) Vav3 and Rac GTPases is required for leukemogenesis mediated by the oncogenic fusion protein BCR-ABL. Vav3 expression becomes predominantly nuclear upon expression of BCR-ABL signature. In the nucleus, Vav3 interacts with BCR-ABL, Rac, and the polycomb repression complex (PRC) proteins Bmi1, Ring1b and Ezh2. The GEF activity of Vav3 is required for the proliferation, Bmi1-dependent B-cell progenitor self-renewal, nuclear Rac activation, protein interaction with Bmi1, mono-ubiquitination of H2A(K119) (H2AK119Ub) and repression of PRC-1 (PRC1) downstream target loci, of leukemic B-cell progenitors. Vav3 deficiency results in de-repression of negative regulators of cell proliferation and repression of oncogenic transcriptional factors. Mechanistically, we show that Vav3 prevents the Phlpp2-sensitive and Akt (S473)-dependent phosphorylation of Bmi1 on the regulatory residue S314 that, in turn, promotes the transcriptional factor reprogramming of leukemic B-cell progenitors. These results highlight the importance of non-canonical nuclear Rho GTPase signaling in leukemogenesis.<\/jats:p>","DOI":"10.1038\/s41467-022-30651-7","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T10:04:08Z","timestamp":1654077848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemogenesis"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-8152","authenticated-orcid":false,"given":"R. C.","family":"Nayak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6486-3898","authenticated-orcid":false,"given":"M.","family":"Kotliar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Wellendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-2982","authenticated-orcid":false,"given":"B.","family":"Mizukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-1205","authenticated-orcid":false,"given":"M.","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3965-6894","authenticated-orcid":false,"given":"P.","family":"Dexheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-5316","authenticated-orcid":false,"given":"A.","family":"Barski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9398-6072","authenticated-orcid":false,"given":"X. R.","family":"Bustelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0481-4784","authenticated-orcid":false,"given":"N. N.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-7233","authenticated-orcid":false,"given":"J. A.","family":"Cancelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"30651_CR1","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","volume":"118","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 118, 3080\u20133087 (2011).","journal-title":"Blood"},{"key":"30651_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts, K. G. et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. New Engl. J. Med. 371, 1005\u20131015 (2014).","journal-title":"New Engl. J. Med."},{"key":"30651_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nm1253","volume":"11","author":"A Castor","year":"2005","unstructured":"Castor, A. et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat. Med. 11, 630\u2013637 (2005).","journal-title":"Nat. Med."},{"key":"30651_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJM200004063421402","volume":"342","author":"M Arico","year":"2000","unstructured":"Arico, M. et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. New Engl. J. Med. 342, 998\u20131006 (2000).","journal-title":"New Engl. J. Med."},{"key":"30651_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","volume":"129","author":"N Jain","year":"2017","unstructured":"Jain, N. et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood 129, 572\u2013581 (2017).","journal-title":"Blood"},{"key":"30651_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","volume":"22","author":"KG Roberts","year":"2012","unstructured":"Roberts, K. G. et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 22, 153\u2013166 (2012).","journal-title":"Cancer Cell"},{"key":"30651_CR7","doi-asserted-by":"publisher","first-page":"101096","DOI":"10.1016\/j.beha.2019.101096","volume":"32","author":"L Maese","year":"2019","unstructured":"Maese, L. & Raetz, E. A. Can Ph-like ALL be effectively targeted? Best. Pract. Res Clin. Haematol. 32, 101096 (2019).","journal-title":"Best. Pract. Res Clin. Haematol."},{"key":"30651_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1182\/blood-2006-12-065599","volume":"110","author":"M Mohty","year":"2007","unstructured":"Mohty, M., Yong, A. S., Szydlo, R. M., Apperley, J. F. & Melo, J. V. The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood 110, 380\u2013383 (2007).","journal-title":"Blood"},{"key":"30651_CR9","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","volume":"116","author":"A Rizo","year":"2010","unstructured":"Rizo, A. et al. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Blood 116, 4621\u20134630 (2010).","journal-title":"Blood"},{"key":"30651_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1182\/blood-2011-06-359232","volume":"119","author":"A Sengupta","year":"2012","unstructured":"Sengupta, A., Ficker, A. M., Dunn, S. K., Madhu, M. & Cancelas, J. A. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells. Blood 119, 494\u2013502 (2012).","journal-title":"Blood"},{"key":"30651_CR11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood.V85.8.2013.bloodjournal8582013","volume":"85","author":"H Sill","year":"1995","unstructured":"Sill, H., Goldman, J. M. & Cross, N. C. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 85, 2013\u20132016 (1995).","journal-title":"Blood"},{"key":"30651_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758\u2013764 (2007).","journal-title":"Nature"},{"key":"30651_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06866","volume":"453","author":"CG Mullighan","year":"2008","unstructured":"Mullighan, C. G. et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453, 110\u2013114 (2008).","journal-title":"Nature"},{"key":"30651_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ccell.2015.07.016","volume":"28","author":"ML Churchman","year":"2015","unstructured":"Churchman, M. L. et al. Efficacy of retinoids in IKZF1-mutated BCR-ABL1 acute lymphoblastic leukemia. Cancer Cell 28, 343\u2013356 (2015).","journal-title":"Cancer Cell"},{"key":"30651_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc2368-c1","volume":"8","author":"RT Williams","year":"2008","unstructured":"Williams, R. T. & Sherr, C. J. BCR-ABL and CDKN2A: a dropped connection. Nat. Rev. Cancer 8, 563 (2008). author reply 563.","journal-title":"Nat. Rev. Cancer"},{"key":"30651_CR16","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1172\/JCI66203","volume":"123","author":"ME Figueroa","year":"2013","unstructured":"Figueroa, M. E. et al. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J. Clin. Invest. 123, 3099\u20133111 (2013).","journal-title":"J. Clin. Invest."},{"key":"30651_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07846-y","volume":"10","author":"RC Nayak","year":"2019","unstructured":"Nayak, R. C. et al. The signaling axis atypical protein kinase C lambda\/iota-Satb2 mediates leukemic transformation of B-cell progenitors. Nat. Commun. 10, 46 (2019).","journal-title":"Nat. Commun."},{"key":"30651_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/16476","volume":"397","author":"JJ Jacobs","year":"1999","unstructured":"Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164\u2013168 (1999).","journal-title":"Nature"},{"key":"30651_CR19","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/leu.2016.70","volume":"30","author":"SA Mariani","year":"2016","unstructured":"Mariani, S. A. et al. CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia. Leukemia 30, 1682\u20131690 (2016).","journal-title":"Leukemia"},{"key":"30651_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard, J. & Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255\u2013260 (2003).","journal-title":"Nature"},{"key":"30651_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature01587","volume":"423","author":"IK Park","year":"2003","unstructured":"Park, I. K. et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302\u2013305 (2003).","journal-title":"Nature"},{"key":"30651_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ccr.2007.10.015","volume":"12","author":"EK Thomas","year":"2007","unstructured":"Thomas, E. K. et al. Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. Cancer Cell 12, 467\u2013478 (2007).","journal-title":"Cancer Cell"},{"key":"30651_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1182\/blood-2009-10-247437","volume":"116","author":"A Sengupta","year":"2010","unstructured":"Sengupta, A., Arnett, J., Dunn, S., Williams, D. A. & Cancelas, J. A. Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo. Blood 116, 81\u201384 (2010).","journal-title":"Blood"},{"key":"30651_CR24","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.256.5060.1196","volume":"256","author":"XR Bustelo","year":"1992","unstructured":"Bustelo, X. R. & Barbacid, M. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 256, 1196\u20131199 (1992).","journal-title":"Science"},{"key":"30651_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/356068a0","volume":"356","author":"XR Bustelo","year":"1992","unstructured":"Bustelo, X. R., Ledbetter, J. A. & Barbacid, M. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 356, 68\u201371 (1992).","journal-title":"Nature"},{"key":"30651_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/385169a0","volume":"385","author":"P Crespo","year":"1997","unstructured":"Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S. & Bustelo, X. R. Phosphotyrosine-dependent activation of Rac-1 GDP\/GTP exchange by the vav proto-oncogene product. Nature 385, 169\u2013172 (1997).","journal-title":"Nature"},{"key":"30651_CR27","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.1093\/emboj\/17.22.6608","volume":"17","author":"KE Schuebel","year":"1998","unstructured":"Schuebel, K. E., Movilla, N., Rosa, J. L. & Bustelo, X. R. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J. 17, 6608\u20136621 (1998).","journal-title":"EMBO J."},{"key":"30651_CR28","doi-asserted-by":"crossref","unstructured":"Rodriguez-Fdez, S. & Bustelo, X. R. The Vav GEF family: an evolutionary and functional perspective. Cells 8, 465 (2019).","DOI":"10.3390\/cells8050465"},{"key":"30651_CR29","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.1128\/MCB.19.11.7870","volume":"19","author":"N Movilla","year":"1999","unstructured":"Movilla, N. & Bustelo, X. R. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol. Cell Biol. 19, 7870\u20137885 (1999).","journal-title":"Mol. Cell Biol."},{"key":"30651_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1182\/blood-2011-06-361709","volume":"120","author":"KH Chang","year":"2012","unstructured":"Chang, K. H. et al. Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival. Blood 120, 800\u2013811 (2012).","journal-title":"Blood"},{"key":"30651_CR31","doi-asserted-by":"crossref","unstructured":"Hegde, S. et al. Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia. Leukemia 36, 637\u2013647 (2021).","DOI":"10.1038\/s41375-021-01455-3"},{"key":"30651_CR32","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1073\/pnas.1722617115","volume":"115","author":"T Xiao","year":"2018","unstructured":"Xiao, T. et al. Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proc. Natl Acad. Sci. USA 115, 7869\u20137878 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30651_CR33","doi-asserted-by":"publisher","first-page":"ra71","DOI":"10.1126\/scisignal.2002962","volume":"5","author":"C Citterio","year":"2012","unstructured":"Citterio, C. et al. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells. Sci. Signal. 5, ra71 (2012).","journal-title":"Sci. Signal."},{"key":"30651_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3664","volume":"16","author":"H Aguilar","year":"2014","unstructured":"Aguilar, H. et al. VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 16, R53 (2014).","journal-title":"Breast Cancer Res."},{"key":"30651_CR35","doi-asserted-by":"publisher","first-page":"e1001615","DOI":"10.1371\/journal.pbio.1001615","volume":"11","author":"M Menacho-Marquez","year":"2013","unstructured":"Menacho-Marquez, M. et al. The Rho exchange factors Vav2 and Vav3 favor skin tumor initiation and promotion by engaging extracellular signaling loops. PLoS Biol. 11, e1001615 (2013).","journal-title":"PLoS Biol."},{"key":"30651_CR36","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra020777","volume":"349","author":"JM Goldman","year":"2003","unstructured":"Goldman, J. M. & Melo, J. V. Chronic myeloid leukemia\u2013advances in biology and new approaches to treatment. New Engl. J. Med. 349, 1451\u20131464 (2003).","journal-title":"New Engl. J. Med."},{"key":"30651_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0091-679X(04)75034-7","volume":"75","author":"U Landegren","year":"2004","unstructured":"Landegren, U. et al. Prospects for in situ analyses of individual and complexes of DNA, RNA, and protein molecules with padlock and proximity probes. Methods Cell Biol. 75, 787\u2013797 (2004).","journal-title":"Methods Cell Biol."},{"key":"30651_CR38","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. A cis-element within the ARF locus mediates repression of p16 (INK4A) expression via long-range chromatin interactions. Proc Natl Acad Sci USA 116, 26644\u201326652 (2019).","DOI":"10.1073\/pnas.1909720116"},{"key":"30651_CR39","doi-asserted-by":"publisher","first-page":"e1008280","DOI":"10.1371\/journal.pgen.1008280","volume":"15","author":"K Okuyama","year":"2019","unstructured":"Okuyama, K. et al. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia. PLoS Genet. 15, e1008280 (2019).","journal-title":"PLoS Genet."},{"key":"30651_CR40","doi-asserted-by":"crossref","unstructured":"Roberts, K. G. & Mullighan, C. G. The biology of B-progenitor acute lymphoblastic leukemia. Cold Spring Harb. Perspect. Med. Leukemia 10, a034835 (2019).","DOI":"10.1101\/cshperspect.a034835"},{"key":"30651_CR41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41588-019-0375-1","volume":"51","author":"I Iacobucci","year":"2019","unstructured":"Iacobucci, I. et al. Genomic subtyping and therapeutic targeting of acute erythroleukemia. Nat. Genet. 51, 694\u2013704 (2019).","journal-title":"Nat. Genet."},{"key":"30651_CR42","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1182\/blood.2020004834","volume":"135","author":"TK Ko","year":"2020","unstructured":"Ko, T. K. et al. An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia. Blood 135, 2337\u20132353 (2020).","journal-title":"Blood"},{"key":"30651_CR43","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1128\/MCB.16.6.3066","volume":"16","author":"O Hobert","year":"1996","unstructured":"Hobert, O., Jallal, B. & Ullrich, A. Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression. Mol. Cell Biol. 16, 3066\u20133073 (1996).","journal-title":"Mol. Cell Biol."},{"key":"30651_CR44","doi-asserted-by":"publisher","first-page":"11047","DOI":"10.1128\/MCB.25.24.11047-11058.2005","volume":"25","author":"I Hernandez-Munoz","year":"2005","unstructured":"Hernandez-Munoz, I., Taghavi, P., Kuijl, C., Neefjes, J. & van Lohuizen, M. Association of BMI1 with polycomb bodies is dynamic and requires PRC2\/EZH2 and the maintenance DNA methyltransferase DNMT1. Mol. Cell Biol. 25, 11047\u201311058 (2005).","journal-title":"Mol. Cell Biol."},{"key":"30651_CR45","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molcel.2005.12.002","volume":"20","author":"R Cao","year":"2005","unstructured":"Cao, R., Tsukada, Y. & Zhang, Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20, 845\u2013854 (2005).","journal-title":"Mol. Cell"},{"key":"30651_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.molcel.2019.12.001","volume":"77","author":"NP Blackledge","year":"2020","unstructured":"Blackledge, N. P. et al. PRC1 catalytic activity is central to polycomb system function. Mol. Cell 77, 857\u2013874.e9 (2020).","journal-title":"Mol. Cell"},{"key":"30651_CR47","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","volume":"113","author":"S Sulong","year":"2009","unstructured":"Sulong, S. et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood 113, 100\u2013107 (2009).","journal-title":"Blood"},{"key":"30651_CR48","first-page":"2343","volume":"42","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells. Int. J. Mol. Med. 42, 2343\u20132352 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"30651_CR49","doi-asserted-by":"crossref","unstructured":"Dong, G. et al. ZFHX3 Promotes the Proliferation and Tumor Growth of ER-Positive Breast Cancer Cells Likely by Enhancing Stem-Like Features and MYC and TBX3 Transcription. Cancers (Basel) 12, 3415 (2020).","DOI":"10.3390\/cancers12113415"},{"key":"30651_CR50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.celrep.2016.05.094","volume":"16","author":"NM Vegi","year":"2016","unstructured":"Vegi, N. M. et al. MEIS2 Is an oncogenic partner in AML1-ETO-positive AML. Cell Rep. 16, 498\u2013507 (2016).","journal-title":"Cell Rep."},{"key":"30651_CR51","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrc3621","volume":"13","author":"DC Bersten","year":"2013","unstructured":"Bersten, D. C., Sullivan, A. E., Peet, D. J. & Whitelaw, M. L. bHLH-PAS proteins in cancer. Nat. Rev. Cancer 13, 827\u2013841 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"30651_CR52","first-page":"ra77","volume":"5","author":"Y Liu","year":"2012","unstructured":"Liu, Y. et al. Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. Sci. Signal 5, ra77 (2012).","journal-title":"Sci. Signal"},{"key":"30651_CR53","first-page":"447","volume":"70","author":"L Pegoraro","year":"1983","unstructured":"Pegoraro, L. et al. Establishment of a Ph1-positive human cell line (BV173). J. Natl Cancer Inst. 70, 447\u2013453 (1983).","journal-title":"J. Natl Cancer Inst."},{"key":"30651_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/jnci\/59.1.83","volume":"59","author":"J Minowada","year":"1977","unstructured":"Minowada, J., Tsubota, T., Greaves, M. F. & Walters, T. R. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens. J. Natl Cancer Inst. 59, 83\u201387 (1977).","journal-title":"J. Natl Cancer Inst."},{"key":"30651_CR55","first-page":"2876","volume":"48","author":"L Naumovski","year":"1988","unstructured":"Naumovski, L. et al. Philadelphia chromosome-positive acute lymphoblastic leukemia cell lines without classical breakpoint cluster region rearrangement. Cancer Res. 48, 2876\u20132879 (1988).","journal-title":"Cancer Res."},{"key":"30651_CR56","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1182\/blood.V69.4.990.990","volume":"69","author":"M Okabe","year":"1987","unstructured":"Okabe, M. et al. Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Blood 69, 990\u2013998 (1987).","journal-title":"Blood"},{"key":"30651_CR57","doi-asserted-by":"publisher","first-page":"10832","DOI":"10.1073\/pnas.170276797","volume":"97","author":"S Sato","year":"2000","unstructured":"Sato, S., Fujita, N. & Tsuruo, T. Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl Acad. Sci. USA 97, 10832\u201310837 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30651_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molcel.2005.03.008","volume":"18","author":"T Gao","year":"2005","unstructured":"Gao, T., Furnari, F. & Newton, A. C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18, 13\u201324 (2005).","journal-title":"Mol. Cell"},{"key":"30651_CR59","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrm2763","volume":"10","author":"JA Simon","year":"2009","unstructured":"Simon, J. A. & Kingston, R. E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 10, 697\u2013708 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"30651_CR60","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.molcel.2012.01.002","volume":"45","author":"Z Gao","year":"2012","unstructured":"Gao, Z. et al. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol. Cell 45, 344\u2013356 (2012).","journal-title":"Mol. Cell"},{"key":"30651_CR61","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrm4067","volume":"16","author":"NP Blackledge","year":"2015","unstructured":"Blackledge, N. P., Rose, N. R. & Klose, R. J. Targeting Polycomb systems to regulate gene expression: modifications to a complex story. Nat. Rev. Mol. Cell Biol. 16, 643\u2013649 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"30651_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.stem.2010.01.005","volume":"6","author":"H Oguro","year":"2010","unstructured":"Oguro, H. et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell 6, 279\u2013286 (2010).","journal-title":"Cell Stem Cell"},{"key":"30651_CR63","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1172\/JCI57477","volume":"122","author":"K Nacerddine","year":"2012","unstructured":"Nacerddine, K. et al. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer. J. Clin. Investig. 122, 1920\u20131932 (2012).","journal-title":"J. Clin. Investig."},{"key":"30651_CR64","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","volume":"25","author":"J Brognard","year":"2007","unstructured":"Brognard, J., Sierecki, E., Gao, T. & Newton, A. C. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell 25, 917\u2013931 (2007).","journal-title":"Mol. Cell"},{"key":"30651_CR65","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1038\/sj.leu.2404842","volume":"21","author":"A Sengupta","year":"2007","unstructured":"Sengupta, A. & Banerjee, S. Pleiotropic p27(Kip1), BCR-ABL and leukemic stem cell: the trio in concert. Leukemia 21, 2559\u20132561 (2007).","journal-title":"Leukemia"},{"key":"30651_CR66","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1038\/s41388-018-0374-1","volume":"37","author":"M Peng","year":"2018","unstructured":"Peng, M. et al. PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein. Oncogene 37, 5735\u20135748 (2018).","journal-title":"Oncogene"},{"key":"30651_CR67","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/ncb1433","volume":"8","author":"X Wu","year":"2006","unstructured":"Wu, X. et al. Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners. Nat. Cell Biol. 8, 756\u2013763 (2006).","journal-title":"Nat. Cell Biol."},{"key":"30651_CR68","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.molcel.2017.01.009","volume":"65","author":"S Kundu","year":"2017","unstructured":"Kundu, S. et al. Polycomb repressive complex 1 generates discrete compacted domains that change during differentiation. Mol. Cell 65, 432\u2013446 e5 (2017).","journal-title":"Mol. Cell"},{"key":"30651_CR69","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1240376","volume":"341","author":"K Miyamoto","year":"2013","unstructured":"Miyamoto, K. et al. Nuclear Wave1 is required for reprogramming transcription in oocytes and for normal development. Science 341, 1002\u20131005 (2013).","journal-title":"Science"},{"key":"30651_CR70","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ncb3387","volume":"18","author":"HQ Le","year":"2016","unstructured":"Le, H. Q. et al. Mechanical regulation of transcription controls Polycomb-mediated gene silencing during lineage commitment. Nat. Cell Biol. 18, 864\u2013875 (2016).","journal-title":"Nat. Cell Biol."},{"key":"30651_CR71","doi-asserted-by":"publisher","first-page":"e1900192","DOI":"10.1002\/bies.201900192","volume":"42","author":"I Cohen","year":"2020","unstructured":"Cohen, I., Bar, C. & Ezhkova, E. Activity of PRC1 and histone H2AK119 monoubiquitination: revising popular misconceptions. Bioessays 42, e1900192 (2020).","journal-title":"Bioessays"},{"key":"30651_CR72","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.20030874","volume":"198","author":"K Fujikawa","year":"2003","unstructured":"Fujikawa, K. et al. Vav1\/2\/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J. Exp. Med. 198, 1595\u20131608 (2003).","journal-title":"J. Exp. Med."},{"key":"30651_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1074-7613(00)80019-9","volume":"10","author":"AW Roberts","year":"1999","unstructured":"Roberts, A. W. et al. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 10, 183\u2013196 (1999).","journal-title":"Immunity"},{"key":"30651_CR74","first-page":"1646","volume":"96","author":"DA Williams","year":"2000","unstructured":"Williams, D. A. et al. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 96, 1646\u20131654 (2000).","journal-title":"Blood"},{"key":"30651_CR75","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1101\/gad.1743709","volume":"23","author":"CA Fasano","year":"2009","unstructured":"Fasano, C. A. et al. Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev. 23, 561\u2013574 (2009).","journal-title":"Genes Dev."},{"key":"30651_CR76","doi-asserted-by":"publisher","first-page":"W755","DOI":"10.1093\/nar\/gkq405","volume":"38","author":"D Emig","year":"2010","unstructured":"Emig, D. et al. AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res. 38, W755\u2013W762 (2010).","journal-title":"Nucleic Acids Res."},{"key":"30651_CR77","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","volume":"37","author":"J Chen","year":"2009","unstructured":"Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305\u2013W311 (2009).","journal-title":"Nucleic Acids Res."},{"key":"30651_CR78","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"30651_CR79","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nprot.2018.015","volume":"13","author":"PJ Skene","year":"2018","unstructured":"Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006\u20131019 (2018).","journal-title":"Nat. Protoc."},{"key":"30651_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","journal-title":"Genome Biol."},{"key":"30651_CR81","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"30651_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"30651_CR83","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ramirez","year":"2016","unstructured":"Ramirez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res."},{"key":"30651_CR84","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes, C. S. et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389\u2013393 (2012).","journal-title":"Nature"},{"key":"30651_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/srep16923","volume":"5","author":"M Wang","year":"2015","unstructured":"Wang, M., Zhao, Y. & Zhang, B. Efficient test and visualization of multi-set intersections. Sci. Rep. 5, 16923 (2015).","journal-title":"Sci. Rep."},{"key":"30651_CR86","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"30651_CR87","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: genome-wide copy number detection and visualization from targeted DNA Sequencing. PLoS Comput. Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30651-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30651-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30651-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:37:47Z","timestamp":1669311467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30651-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30651"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30651-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"14 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B. is a co-founder of Datirium, LLC. Datirium developed SciDAP bioinformatics platform used for data analysis in this study. Other authors have no relevant conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3056"}}